Article
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.
Immunity - 20 Sept 2016
Steichen Jon M, Kulp Daniel W, Tokatlian Talar, Escolano Amelia, Dosenovic Pia, Stanfield Robyn L, McCoy Laura E, Ozorowski Gabriel, Hu Xiaozhen, Kalyuzhniy Oleksandr, Briney Bryan, Schiffner Torben, Garces Fernando, Freund Natalia T, Gitlin Alexander D, Menis Sergey, Georgeson Erik, Kubitz Michael, Adachi Yumiko, Jones Meaghan, Mutafyan Andrew A, Yun Dong Soo, Mayer Christian T, Ward Andrew B, Burton Dennis R, Wilson Ian A, Irvine Darrell J, Nussenzweig Michel C, Schief William R
Abstract excerpt
Broadly neutralizing antibodies (bnAbs) against the N332 supersite of the HIV envelope (Env) trimer are the most common bnAbs induced during infection, making them promising leads for vaccine design. Wild-type Env glycoproteins lack detectable affinity for supersite-bnAb germline precursors and are therefore unsuitable immunogens to prime supersite-bnAb responses. We employed mammalian cell surface display to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
